Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
43,643,682
-
Shares change
-
-2,833,019
-
Total reported value, excl. options
-
$8,061,061,147
-
Value change
-
-$556,417,441
-
Put/Call ratio
-
82%
-
Number of buys
-
104
-
Number of sells
-
103
-
Price
-
$184.71
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2024
As of 31 Dec 2024 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,643,682 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, Capital International Investors, PRIMECAP MANAGEMENT CO/CA/, HHLR ADVISORS, LTD., BAILLIE GIFFORD & CO, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Temasek Holdings (Private) Ltd, MORGAN STANLEY, and BlackRock, Inc..
This table shows 271 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.